Ambalal Sarabhai Enterprise Ltd.

Web: ase.life NSE: AMBALALSA BSE: 500009 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

32 0(-1%)

Near 52W Low of 30

Volume

30k as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

55/100

Growth Score

63/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

248

No. of Shares

7.66

P/E

51.34

P/B

11.23

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

21.89

ROCE

Profit Growth

Listing Date

Promoter Holding

31.36%

FII Holding

DII Holding

Price Chart

Price Performance

1 Week0%

1 Month2%

3 Months1%

6 Months1%

1 Year1%

YTD1%

Moving Average

5 Day SMA32

10 Day SMA32

20 Day SMA34

30 Day SMA33

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	34	32	33	34
Resistance 2	33	32	33	33
Resistance 1	33	32	33	32
Pivot Point	32	32	32	32
Support 1	31	32	32	31
Support 2	31	32	31	31
Support 3	30	31	31	30

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,66,156	1943	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,91,668	7220	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,68,504	4979	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,26,451	8794	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,825	1409	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,902	1112	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,08,410	2371	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,104	1080	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,03,745	2512	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	96,236	1153	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 31.36%	(0.01) 31.36%	(0.01) 31.35%	(0.01) 31.35%	(0.01) 31.35%	(0.01) 31.35%	(0.61) 31.35%	(0.01) 30.78%	(0.01) 30.78%	(0.01) 30.78%	(0.01) 30.78%	(0.01) 30.78%	(0.01) 30.77%	(0.01) 30.77%	(0.01) 30.76%	(0.01) 30.76%	(0.01) 30.76%	(0.01) 30.76%
FIIs	(-0.31) 0.00%	(0.01) 0.34%	(0.01) 0.34%	(0.01) 0.38%	(0.41) 0.38%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(0.01) 0.10%	(0.11) 0.10%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%
Public	68.64%	68.29%	68.32%	68.26%	68.18%	68.54%	68.65%	69.22%	69.23%	69.21%	69.23%	69.22%	69.22%	69.23%	69.23%	69.24%	69.24%	69.24%
No. of Shareholders	167,599	168,396	170,015	169,630	170,912	171,221	172,338	169,228	170,079	171,944	175,222	177,743	178,274	179,404	180,199	181,589	181,213	182,946

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	65.49	52	44.45	40.34	64.81	45.97	44.7	40.7	54.35	43.11	40.01	36.1	44.44	35.36	46.84	43.65	54.43	43.1	56.49
Sales Growth % (YoY)	1%	13.1%	-0.6%	-0.9%	19.2%	6.6%	11.7%	12.7%	22.3%	21.9%	-14.6%	-17.3%	-18.4%	-18%	-17.1%	2.2%	12.3%	-6.4%	33.2%
Sales Growth % (QoQ)	25.9%	17%	10.2%	-37.8%	41%	2.8%	9.8%	-25.1%	26.1%	7.7%	10.8%	-18.8%	25.7%	-24.5%	7.3%	-19.8%	26.3%	-23.7%	-
Expenses	59.79	47.92	44.09	38.88	59.51	46.67	42.16	40.23	49.7	40.58	39	40.07	41.09	33.79	46.11	42.91	53.09	37.15	46.63
Operating Profit	5.7	4.08	0.36	1.46	5.3	-0.7	2.54	0.47	4.65	2.53	1.01	-3.97	3.35	1.57	0.73	0.74	1.34	5.95	9.86
OPM %	8.7	7.85	0.81	3.62	8.18	-1.52	5.68	1.15	8.56	5.87	2.52	-11	7.54	4.44	1.56	1.7	2.46	13.81	17.45
Other Income	3.02	1.94	1.62	8.36	-5.37	5.76	2.8	2.3	4.79	1.63	2.85	1.37	5.71	3.06	2.38	2.69	8.54	0.65	1.99
Interest	1.42	0.7	0.96	1.01	0.96	1.14	1.22	0.95	0.9	0.99	0.92	0.95	0.99	0.56	0.45	0.43	0.45	0.33	0.34
Depreciation	1.05	0.96	1.06	0.88	1.02	0.99	1.01	0.98	0.25	1.13	1.14	1.05	0.92	0.61	0.62	0.6	0.62	0.58	0.56
Profit before tax	6.25	4.36	-0.04	7.93	-2.05	2.93	3.11	0.84	8.29	2.04	1.8	-4.6	7.15	3.46	2.04	2.4	8.81	5.69	10.95
Tax %	-4	16.51	1300	-3.66	-86.83	23.89	15.76	59.52	-8.69	34.31	40	5.87	20.14	12.72	50	34.17	13.96	38.49	12.97
Net Profit	6.5	3.64	-0.56	8.22	-0.27	2.23	2.62	0.35	9.02	1.33	1.08	-4.87	5.71	3.01	1.02	1.58	7.59	3.5	9.53
Net Profit Growth % (QoQ)	78.6%	750%	-106.8%	3144.4%	-112.1%	-14.9%	648.6%	-96.1%	578.2%	23.1%	122.2%	-185.3%	89.7%	195.1%	-35.4%	-79.2%	116.9%	-63.3%	-
Net Profit Growth % (YoY)	2507.4%	63.2%	-121.4%	2248.6%	-103%	67.7%	142.6%	107.2%	58%	-55.8%	5.9%	-408.2%	-24.8%	-14%	-89.3%	-	-	-	-
TTM Net Profit	17.8	11.03	9.62	12.8	4.93	14.22	13.32	11.78	6.56	3.25	4.93	4.87	11.32	13.2	13.69	22.2	20.62	13.03	0
EPS in Rs	0.85	0.47	-0.07	1.07	-0.04	0.29	0.34	0.05	1.18	0.17	0.14	-0.64	0.75	0.39	0.13	0.21	0.99	0.46	1.24

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	202	196	173	170	197	163	133	150	125	134	132	124	105	100
Sales Growth %	3.2%	13%	1.9%	-13.4%	20.3%	22.9%	-11.6%	20.2%	-6.6%	1.4%	6%	19%	4.4%	12.7%
Expenses	190	187	167	162	171	165	136	144	137	137	145	129	112	111
Operating Profit	12	9	6	8	25	-2	-3	6	-12	-3	-13	-4	-7	-10
OPM %	6	5	3	5	13	-1	-2	4	-9	-2	-10	-3	-7	-10
Other Income	15	5	10	12	33	40	24	8	25	-2	95	13	2	16
Interest	4	5	6	3	2	3	4	3	3	5	4	10	11	9
Depreciation	4	4	4	3	2	2	3	2	2	4	17	5	3	14
Profit before tax	19	5	7	15	54	33	15	8	8	-14	62	-6	-20	-16
Tax %	4	-2	15	25	13	10	6	48	84	34	22	13	3	11
Net Profit	18	5	6	11	47	29	14	4	1	-18	48	-7	-20	-18
Net Profit Growth %	260%	-16.7%	-45.5%	-76.6%	62.1%	107.1%	250%	300%	105.6%	-137.5%	785.7%	65%	-11.1%	-
EPS in Rs	2.32	0.64	0.74	1.49	6.16	3.83	1.83	0.55	0.17	-2.38	6.28	-0.87	-2.64	-2.39
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	13	-18	9	6	11	-2	-7	19	-7	5	-75	-8	11	-3
Cash from Investing Activity	-10	13	-5	-17	5	10	17	-9	18	-3	80	10	-1	0
Cash from Financing Activity	-2	-2	-3	9	-19	-6	-14	-6	-2	-6	-3	-1	-8	3
Net Cash Flow	1	-6	1	-2	-3	2	-4	3	8	-4	2	1	2	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	77	77	77	77	77	77	77	77	77	77	77	77	77	77	77	77
Reserves	82	71	63	64	60	54	43	-3	-32	-46	-50	-51	-38	-86	-79	-59
Borrowings	57	47	51	51	46	45	27	28	31	40	43	42	47	46	42	39
Other Liabilities	66	66	79	69	67	70	84	108	111	144	128	93	94	132	128	110
Total Liabilities	281	260	270	260	250	246	231	210	186	214	197	160	180	169	167	167
Fixed Assets	91	87	87	89	88	85	58	57	57	58	59	72	72	91	94	98
CWIP	2	0	0	0	0	4	12	1	0	24	14	3	9	1	0	0
Investments	32	32	32	32	29	32	33	27	18	9	5	5	8	1	1	1
Other Assets	156	141	151	139	133	125	128	125	110	123	119	80	92	76	71	67
Total Assets	281	260	270	260	250	246	231	210	186	214	197	160	180	169	167	167

Delivery

#	Date	30 28% 38	Value (Cr)	Q/T 148	Del 62	Del 0
1	24-Jul	32	0	88	81	0
2	23-Jul	33	1	179	73	1
3	22-Jul	31	0	87	69	0
4	21-Jul	32	0	67	53	0
5	20-Jul	31	0	108	73	0
6	17-Jul	31	0	97	62	0
7	16-Jul	31	0	81	62	0
8	15-Jul	31	0	120	48	0
9	14-Jul	31	0	85	74	0
10	13-Jul	31	0	107	76	0
11	10-Jul	31	0	62	75	0
12	9-Jul	31	0	99	81	0
13	8-Jul	32	0	146	66	0
14	7-Jul	32	0	51	42	0
15	6-Jul	32	0	96	59	0
16	3-Jul	33	0	94	67	0
17	2-Jul	32	0	94	76	0
18	1-Jul	32	0	75	66	0
19	30-Jun	33	0	176	71	0
20	29-Jun	31	0	107	73	0
21	25-Jun	32	0	147	65	0
22	24-Jun	31	0	183	59	0
23	23-Jun	32	0	117	66	0
24	22-Jun	32	0	108	75	0
25	19-Jun	32	0	150	80	0
26	18-Jun	32	0	75	55	0
27	17-Jun	32	0	60	69	0
28	16-Jun	32	0	80	67	0
29	15-Jun	33	0	124	57	0
30	12-Jun	33	0	97	56	0
31	11-Jun	31	0	132	71	0
32	10-Jun	33	0	96	61	0
33	9-Jun	34	1	246	69	0
34	8-Jun	35	0	96	56	0
35	5-Jun	34	0	121	59	0
36	4-Jun	35	0	83	62	0
37	3-Jun	36	1	83	60	0
38	2-Jun	37	1	101	44	1
39	1-Jun	36	1	134	53	0
40	29-May	35	1	108	48	0
41	27-May	35	1	109	55	1
42	26-May	32	0	90	60	0
43	25-May	32	0	102	67	0
44	22-May	33	0	87	58	0
45	21-May	33	1	91	54	0
46	20-May	33	0	70	55	0
47	19-May	31	0	119	56	0
48	18-May	31	0	131	65	0
49	15-May	33	0	99	54	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
24-Jul	248c	2c	0.95
23-Jul	251c	13c	5.48
22-Jul	238c	8c	3.13
21-Jul	245c	8c	3.23
17-Jul	238c	2c	0.80
16-Jul	240c	46L	0.19
15-Jul	240c	77L	0.32
14-Jul	239c	3c	1.08
13-Jul	242c	4c	1.48
10-Jul	238c	1c	0.51
09-Jul	240c	6c	2.25
08-Jul	245c	77L	0.31
07-Jul	246c	54L	0.22
06-Jul	245c	1c	0.50
02-Jul	247c	9c	3.39
30-Jun	255c	14c	5.65
29-Jun	242c	4c	1.65
26-Jun	246c	5c	2.17
25-Jun	240c	1c	0.44
24-Jun	241c	9c	3.67
23-Jun	251c	8c	3.15
22-Jun	243c	4c	1.64
19-Jun	247c	3c	0.98
17-Jun	249c	1c	0.49
16-Jun	248c	5c	2.00
15-Jun	253c	1c	0.46
12-Jun	252c	3c	1.23
11-Jun	249c	0	0

Stock Checklist

Price is below from 52 week high low average: 46%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView